Elevated IL-6 is linked to acute COVID-19 symptoms, including complement cascade upregulation, and current COVID-19 treatment regimens include the use of the IL-6 specific monoclonal antibody Tocilizumab [36]. This evidence concerns the gene IL6 and COVID-19.